ReviewJournal of hematology & oncology2021
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma.
Yang Xun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled itcites it